DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Bellmunt J. et al.
IMvigor210: Updated Analyses of First-Line Atezolizumab in Cisplatin-Ineligible Locally Advanced/Metastatic Urothelial Carcinoma.
ESMO; 2016 782PD (Poster)
Access:
We do not assume any responsibility for the contents of the web pages of other providers.